1
|
Ahmad A: Breast Cancer Statistics: Recent
Trends. Adv Exp Med Biol. 1152:1–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Valdora F, Houssami N, Rossi F, Calabrese
M and Tagliafico AS: Rapid review: Radiomics and breast cancer.
Breast Cancer Res Treat. 169:217–229. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhou Y, Huan L, Wu Y, Bao C, Chen B, Wang
L, Huang S, Liang L and He X: lncRNA ID2-AS1 suppresses tumor
metastasis by activating the HDAC8/ID2 pathway in hepatocellular
carcinoma. Cancer Lett. 469:399–409. 2020. View Article : Google Scholar : PubMed/NCBI
|
6
|
He J and Yu J: Long noncoding RNA
FAM83A-AS1 facilitates hepatocellular carcinoma progression by
binding with NOP58 to enhance the mRNA stability of FAM83A. Biosci
Rep. 39:392019. View Article : Google Scholar
|
7
|
Song W, Zhang J, Zhang J, Sun M and Xia Q:
Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by
competitive binding with microRNA-566 to inhibit the growth,
invasion and metastasis of hepatocellular carcinoma cells. Cancer
Cell Int. 19:1502019. View Article : Google Scholar : PubMed/NCBI
|
8
|
Yang Y, Yang H, Xu M, Zhang H, Sun M, Mu
P, Dong T, Du S and Liu K: Long non-coding RNA (lncRNA) MAGI2-AS3
inhibits breast cancer cell growth by targeting the Fas/FasL
signalling pathway. Hum Cell. 31:232–241. 2018. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ai B, Kong X, Wang X, Zhang K, Yang X,
Zhai J, Gao R, Qi Y, Wang J, Wang Z, et al: LINC01355 suppresses
breast cancer growth through FOXO3-mediated transcriptional
repression of CCND1. Cell Death Dis. 10:5022019. View Article : Google Scholar : PubMed/NCBI
|
10
|
Li Y, Zeng Q, Qiu J, Pang T, Xian J and
Zhang X: Long non-coding RNA UCA1 promotes breast cancer by
upregulating PTP1B expression via inhibiting miR-206. Cancer Cell
Int. 19:2752019. View Article : Google Scholar : PubMed/NCBI
|
11
|
Li D, Jiang X, Zhang X, Cao G, Wang D and
Chen Z: Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell
proliferation, migration, and invasion through upregulating CDCA7
via sponging miR-302e. In Vitro Cell Dev Biol Anim. 55:577–585.
2019. View Article : Google Scholar : PubMed/NCBI
|
12
|
Yang Y, Dong MH, Hu HM, Min QH and Xiao L:
lncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and
metastasis of renal cell carcinoma through ERK/AKT signalling. Eur
Rev Med Pharmacol Sci. 24:8756–8766. 2020.PubMed/NCBI
|
13
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Luo Q, Wei C, Li X, Li J, Chen L, Huang Y,
Song H, Li D and Fang L: MicroRNA-195-5p is a potential diagnostic
and therapeutic target for breast cancer. Oncol Rep. 31:1096–1102.
2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Legembre P, Schickel R, Barnhart BC and
Peter ME: Identification of SNF1/AMP kinase-related kinase as an
NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced
motility and invasiveness. J Biol Chem. 279:46742–46747. 2004.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Zagórska A, Deak M, Campbell DG, Banerjee
S, Hirano M, Aizawa S, Prescott AR and Alessi DR: New roles for the
LKB1-NUAK pathway in controlling myosin phosphatase complexes and
cell adhesion. Sci Signal. 3:ra252010. View Article : Google Scholar
|
17
|
Lefebvre DL, Bai Y, Shahmolky N, Sharma M,
Poon R, Drucker DJ and Rosen CF: Identification and
characterization of a novel sucrose-non-fermenting protein
kinase/AMP-activated protein kinase-related protein kinase, SNARK.
Biochem J. 355:297–305. 2001. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yuan WC, Pepe-Mooney B, Galli GG, Dill MT,
Huang HT, Hao M, Wang Y, Liang H, Calogero RA and Camargo FD: NUAK2
is a critical YAP target in liver cancer. Nat Commun. 9:48342018.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Fu TG, Wang L, Li W, Li JZ and Li J:
miR-143 inhibits oncogenic traits by degrading NUAK2 in
glioblastoma. Int J Mol Med. 37:1627–1635. 2016. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tang L, Tong SJ, Zhan Z, Wang Q, Tian Y
and Chen F: Expression of NUAK2 in gastric cancer tissue and its
effects on the proliferation of gastric cancer cells. Exp Ther Med.
13:676–680. 2017. View Article : Google Scholar : PubMed/NCBI
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Ren S, Liu J, Feng Y, Li Z, He L, Li L,
Cao X, Wang Z and Zhang Y: Knockdown of circDENND4C inhibits
glycolysis, migration and invasion by up-regulating miR-200b/c in
breast cancer under hypoxia. J Exp Clin Cancer Res. 38:3882019.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Zhou J, Zhang S, Chen Z, He Z, Xu Y and Li
Z: CircRNA-ENO1 promoted glycolysis and tumor progression in lung
adenocarcinoma through upregulating its host gene ENO1. Cell Death
Dis. 10:8852019. View Article : Google Scholar : PubMed/NCBI
|
24
|
Chi Y, Wang D, Wang J, Yu W and Yang J:
Long Non-Coding RNA in the Pathogenesis of Cancers. Cells. 8:82019.
View Article : Google Scholar
|
25
|
Deng Z, Cai H, Lin L, Zhu L, Wu W, Yang S,
Cai J and Tan J: lncRNA ATXN8OS promotes breast cancer by
sequestering miR 204. Mol Med Rep. 20:1057–1064. 2019.PubMed/NCBI
|
26
|
Pei J and Wang B: Notch-1 promotes breast
cancer cells proliferation by regulating lncRNA GAS5. Int J Clin
Exp Med. 8:14464–14471. 2015.PubMed/NCBI
|
27
|
Liang Y, Song X, Li Y, Chen B, Zhao W,
Wang L, Zhang H, Liu Y, Han D, Zhang N, et al: lncRNA BCRT1
promotes breast cancer progression by targeting miR-1303/PTBP3
axis. Mol Cancer. 19:852020. View Article : Google Scholar : PubMed/NCBI
|
28
|
Militello G, Weirick T, John D, Döring C,
Dimmeler S and Uchida S: Screening and validation of lncRNAs and
circRNAs as miRNA sponges. Brief Bioinform. 18:780–788.
2017.PubMed/NCBI
|
29
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
30
|
Gatenby RA and Gillies RJ: Why do cancers
have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Fu QF, Liu Y, Fan Y, Hua SN, Qu HY, Dong
SW, Li RL, Zhao MY, Zhen Y, Yu XL, et al: Alpha-enolase promotes
cell glycolysis, growth, migration, and invasion in non-small cell
lung cancer through FAK-mediated PI3K/AKT pathway. J Hematol Oncol.
8:222015. View Article : Google Scholar : PubMed/NCBI
|
32
|
Xiong S, Li D, Wang D, Huang L, Liang G,
Wu Z, Long J, Yang D, Teng Y, Lei S, et al: Circular RNA MYLK
Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer
Cells by Sponging miR-195-5p and Increasing Glucose Transporter
Member 3 Expression. Cancer Manag Res. 12:5469–5478. 2020.
View Article : Google Scholar : PubMed/NCBI
|